ID

26340

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacogenetic research Withdrawal of consent

Palabras clave

  1. 9/10/17 9/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 11/1/18 11/1/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

16 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Pharmacogenetic research Withdrawal of consent GSK study Chronic Coronary Heart Disease NCT00799903

    Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

    Withdrawal of consent for PGx (DNA) / Blood sample destruction
    Descripción

    Withdrawal of consent for PGx (DNA) / Blood sample destruction

    1. Has subject withdrawn consent for PGx research?
    Descripción

    withdrawal consent for PGx research

    Tipo de datos

    boolean

    If subject has withdrawn consent for PGx research: date informed consent withdrawn
    Descripción

    date informed consent withdrawn

    Tipo de datos

    date

    2. Has a request been made for blood sample destruction?
    Descripción

    request for blood sample destruction

    Tipo de datos

    boolean

    If a request has been made for blood sample destruction, check reason
    Descripción

    request for blood sample destruction reason

    Tipo de datos

    text

    If other reason applied, specify
    Descripción

    request for blood sample destruction other reason

    Tipo de datos

    text

    Similar models

    Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Withdrawal of consent for PGx (DNA) / Blood sample destruction
    withdrawal consent for PGx research
    Item
    1. Has subject withdrawn consent for PGx research?
    boolean
    date informed consent withdrawn
    Item
    If subject has withdrawn consent for PGx research: date informed consent withdrawn
    date
    request for blood sample destruction
    Item
    2. Has a request been made for blood sample destruction?
    boolean
    Item
    If a request has been made for blood sample destruction, check reason
    text
    Code List
    If a request has been made for blood sample destruction, check reason
    CL Item
    Subject withdrew consent for PGx (3)
    CL Item
    Other (Z)
    request for blood sample destruction other reason
    Item
    If other reason applied, specify
    text

    Utilice este formulario para comentarios, preguntas y sugerencias.

    Los campos marcados con * son obligatorios.

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial